Coherus Oncology Inc (CHRS)

Cash & Equivalents

$82.92M

Quarterly · Period ending: · USD

CHRS logo

CHRS Cash & Equivalents

Latest reported$88.88M
CHRS FY Cash & Equivalents ($14.55M → $88.88M)
High-resolution chart · PNG

CHRS cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
88,879,000
125,987,000
102,891,000
63,547,000
417,195,000
541,158,000
177,668,000
72,356,000
126,911,000
124,947,000
158,226,000
150,392,000
39,554,000
14,548,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.